Skip to main content
. 2022 Dec 2;27(23):8475. doi: 10.3390/molecules27238475
RA-ILD interstitial lung disease associated with rheumatoid arthritis
RA rheumatoid arthritis
ILD interstitial lung disease
Res resveratrol
UIP usual interstitial pneumonitis
LEF leflunomide
ECM extracellular matrix
COPD chronic obstructive pulmonary disease
CFA complete Freund’s adjuvant
BLM bleomycin
H&E hematoxylin–eosin
ROS reactive oxygen species
Ctrl control
CIA collagen-induced arthritis models
CIA+BLM CIA- and bleomycin-treated models
CB+Res CIA+BLM- and resveratrol-treated models